Skip to main content

Table 1 Group comparison between the analysis groups concerning depressivity, gender, age, and substance use frequency

From: Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study

 

MA

noMA

noSUD

Group differences

Total

    

Test statistic (df)

p-value

Effect size

 

N (female)

18 (8)

18 (8)

18 (8)

   

54 (24)

Mean age in years (SD)

16.4 (1.2)

16.0 (1.1)

15.9 (1.3)

F [2, 51] = 0.968

.387

d = 0.41

16.1 (1.2)

Mean BDI-II score (SD)

19.1 (11.5)

16.3 (14.4)

11.0 (12.2)

F [2, 48] = 0.968

.199

d = 0.63

15.7 (12.9)

Average monthly frequency of substance use (in days per month):

 Tobacco (SD, n)

27.5 (7.7, n = 17)

25.0 (10.4, n = 16)

0.75 (2.8, n = 3)

F [1, 34] = 0.668

.419

d = 0.27

17.75 (14.3, n = 36)

 Alcohol (SD, n)

4.7 (7.9, n = 14)

7 (10.1, n = 13)

0

F [1, 34] = 0.563

.458

d = 0.25

3.9 (7.8, n = 27)

 Cannabis (SD, n)

19.9 (12.5, n = 18)

17.0 (12.2, n = 17)

0

F [1, 34] = 0.501

.484

d = 0.24

12.3 (13.3, n = 35)

 Amphetamine (SD, n)

0.7 (1.4, n = 5)

0.3 (1.0, n = 3)

0

F [1, 34] = 0.839

.366

d = 0.31

0.3 (1.0, n = 8)

 MDMA (SD, n)

3.4 (4.2, n = 14)

3.0 (7.6, n = 7)

0

F [1, 34] = 0.037

.848

d = 0.06

2.2 (5.2, n = 21)

 MA (SD, n)

12.7 (13.0, n = 18)

0

0

   

4.2 (9.5, n = 18)

  1. Notes: d, Cohen’s d with 0.2 being considered small, 0.5 medium, and 0.8 large [25]; SD, standard deviation; BDI-II, Beck Depression Inventory II; MA, methamphetamine; MDMA, 3,4-methylendioxymethamphetamine (“ecstasy”)